215 related articles for article (PubMed ID: 29373327)
21. A Case of Salivary Duct Carcinoma Intracranial Invasion due to Perineural Invasion Through the Facial Nerve.
Enomoto T; Aoki M; Miyagawa K; Matsumoto J; Kobayashi H; Takeuchi T; Abe H; Nonaka M; Sakata T; Inoue T; Nabeshima K
World Neurosurg; 2020 Aug; 140():332-337. PubMed ID: 32473330
[TBL] [Abstract][Full Text] [Related]
22. Cervical Lymph Node Metastatic Status and Adjuvant Therapy Predict the Prognosis of Salivary Duct Carcinoma.
Qian K; Di L; Guo K; Zheng X; Ji Q; Wang Z
J Oral Maxillofac Surg; 2018 Jul; 76(7):1578-1586. PubMed ID: 29544756
[TBL] [Abstract][Full Text] [Related]
23. [Survival analysis and immunohistochemical study of HER-2 and AR (androgen receptor) expression in salivary duct carcinoma].
Otsuka K; Imanishi Y; Habu N; Sato Y; Shigetomi S; Fujii R; Sakamoto K; Tomita T; Fujii M; Kameyama K; Ogawa K
Nihon Jibiinkoka Gakkai Kaiho; 2013 Sep; 116(9):1024-32. PubMed ID: 24191589
[TBL] [Abstract][Full Text] [Related]
24. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases.
Jaehne M; Roeser K; Jaekel T; Schepers JD; Albert N; Löning T
Cancer; 2005 Jun; 103(12):2526-33. PubMed ID: 15900577
[TBL] [Abstract][Full Text] [Related]
25. Low-grade salivary duct carcinoma or low-grade intraductal carcinoma? Review of the literature.
Kuo YJ; Weinreb I; Perez-Ordonez B
Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S59-67. PubMed ID: 23821212
[TBL] [Abstract][Full Text] [Related]
26. Androgen receptor immunohistochemistry in salivary duct carcinoma: a retrospective study of 188 cases focusing on tumoral heterogeneity and temporal concordance.
Xu B; Dogan S; Haroon Al Rasheed MR; Ghossein R; Katabi N
Hum Pathol; 2019 Nov; 93():30-36. PubMed ID: 31430492
[TBL] [Abstract][Full Text] [Related]
27. Primary salivary duct carcinoma arising from the Stensen duct.
Noda K; Hirano T; Okamoto T; Suzuki M
Ear Nose Throat J; 2016 Sep; 95(9):E15-7. PubMed ID: 27657321
[TBL] [Abstract][Full Text] [Related]
28. Salivary duct carcinoma of the supraglottis with a distinct presentation: A case report and literature review.
Hsu CC; Li WY; Chu PY
Medicine (Baltimore); 2018 Mar; 97(11):e0095. PubMed ID: 29538201
[TBL] [Abstract][Full Text] [Related]
29. Salivary duct carcinoma: Clinicopathologic features, morphologic spectrum, and somatic mutations.
Luk PP; Weston JD; Yu B; Selinger CI; Ekmejian R; Eviston TJ; Lum T; Gao K; Boyer M; O'Toole SA; Clark JR; Gupta R
Head Neck; 2016 Apr; 38 Suppl 1():E1838-47. PubMed ID: 26699379
[TBL] [Abstract][Full Text] [Related]
30. Early T Stage Salivary Duct Carcinoma: Outcomes and Implications for Patient Counseling.
Schmitt NC; Sharma A; Gilbert MR; Kim S
Otolaryngol Head Neck Surg; 2015 Nov; 153(5):795-8. PubMed ID: 26307577
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors and outcome analysis of salivary duct carcinoma.
Han MW; Roh JL; Choi SH; Nam SY; Lee HJ; Cho KJ; Lee SW; Kim SY
Auris Nasus Larynx; 2015 Dec; 42(6):472-7. PubMed ID: 26028371
[TBL] [Abstract][Full Text] [Related]
32. Genomic alteration in rare subtype of sarcomatoid salivary duct carcinoma.
Jeong JS; Cho KJ; Kim D; Lee YS; Song JS
Pathol Res Pract; 2021 Dec; 228():153678. PubMed ID: 34781210
[TBL] [Abstract][Full Text] [Related]
33. Salivary duct carcinoma in the mandible: a case report.
Kikuchi Y; Hirota M; Iwai T; Aoki S; Chikumaru H; Kawabe R; Matsui Y
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e41-6. PubMed ID: 17321438
[TBL] [Abstract][Full Text] [Related]
34. Intratumoral heterogeneity of HER2 protein and amplification of HER2 gene in salivary duct carcinoma.
Kondo Y; Kikuchi T; Esteban JC; Kumaki N; Ogura G; Inomoto C; Hirabayashi K; Kajiwara H; Sakai A; Sugimoto R; Otsuru M; Okami K; Tsukinoki K; Nakamura N
Pathol Int; 2014 Sep; 64(9):453-9. PubMed ID: 25209856
[TBL] [Abstract][Full Text] [Related]
35. Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications.
Santana T; Pavel A; Martinek P; Steiner P; Grossmann P; Baněčková M; Skálová A
Hum Pathol; 2019 Nov; 93():37-47. PubMed ID: 31437521
[TBL] [Abstract][Full Text] [Related]
36. Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistochemical analysis of 13 cases and review of the literature.
Fan CY; Wang J; Barnes EL
Am J Surg Pathol; 2000 Apr; 24(4):579-86. PubMed ID: 10757407
[TBL] [Abstract][Full Text] [Related]
37. Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes.
Di Palma S; Simpson RH; Marchiò C; Skálová A; Ungari M; Sandison A; Whitaker S; Parry S; Reis-Filho JS
Histopathology; 2012 Oct; 61(4):629-43. PubMed ID: 22882517
[TBL] [Abstract][Full Text] [Related]
38. Salivary duct carcinoma: new developments--morphological variants including pure in situ high grade lesions; proposed molecular classification.
Simpson RH
Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S48-58. PubMed ID: 23821208
[TBL] [Abstract][Full Text] [Related]
39. [Salivary duct carcinomas comprise phenotypically and genotypically diverse high grade neoplasms].
Hungermann D; Korsching E; Bürger H; Röser K; Löning T; Herbst H
Verh Dtsch Ges Pathol; 2006; 90():168-76. PubMed ID: 17867594
[TBL] [Abstract][Full Text] [Related]
40. Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy.
Schmitt NC; Kang H; Sharma A
Oral Oncol; 2017 Nov; 74():40-48. PubMed ID: 29103750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
